The purpose of this observational study is to document the course of disease and relapse management during treatment with Daivobet® Gel under consideration of patient's individual application habits under daily use conditions.
Study Type
OBSERVATIONAL
Enrollment
561
Once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance.
PD Dr. med. Rosenbach
Osnabrück, Lower Saxony, Germany
The Course of Disease and Relapse Management During Treatment With Daivobet® Gel Under Consideration of Patient's Individual Application Habits Under Daily Use Conditions.
Number of exacerbations and relapses during one year observation time
Time frame: 1 year
PGA (Physician's Global Assessment of Psoriasis Vulgaris Severity)
6--point verbal rating scale
Time frame: Baseline
PGA (Physician's Global Assessment of Psoriasis Vulgaris Severity)
Assessment on 6-step scale from "no visible disease (O)" to "very severe disease (5)
Time frame: 1 year
Side Effects
Number of participants with serious and non-serious adverse drug reactions.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.